Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy

A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1

John D. Pirsch, Joshua Miller, Mark H. Deierhoi et al. · Transplantation · 1997 · 1.1K citations

Medicine, Immunology, Nephrology +14

Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

F. Vincenti, Robert L. Kirkman, Susan Light et al. · New England Journal of Medicine · 1998 · 876 citations · Full text

Medicine, Immunology, Pharmacology +17

MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL ALLOGRAFT REJECTION1

A. David Mayer, Jan Dmitrewski, Jean-Paul Squifflet et al. · Transplantation · 1997 · 733 citations

Medicine, Immunology, Kidney Transplantation +9

ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIA

Anders Lindholm, D Albrechtsen, L Frödin et al. · Transplantation · 1995 · 335 citations

Medicine, Nephrology, Surgery +11

RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2

Christopher P. Johnson, Nasimul Ahsan, Thomas A. Gonwa et al. · Transplantation · 2000 · 296 citations

Pharmacy, Nephrology, Pharmacotherapy +17